A Phase 2, Open-Label, Randomized Study of Pexa-Vec (JX-594) Administered by Intratumoral Injection in Patients with Unresectable Primary Hepatocellular Carcinoma (Q38425231)
Jump to navigation
Jump to search
scientific article published on January 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase 2, Open-Label, Randomized Study of Pexa-Vec (JX-594) Administered by Intratumoral Injection in Patients with Unresectable Primary Hepatocellular Carcinoma |
scientific article published on January 2015 |
Statements
1 reference
A Phase 2, Open-Label, Randomized Study of Pexa-Vec (JX-594) Administered by Intratumoral Injection in Patients with Unresectable Primary Hepatocellular Carcinoma (English)
1 reference
Caroline J Breitbach
1 reference
Anne Moon
1 reference
James Burke
1 reference
Tae-Ho Hwang
1 reference
David H Kirn
1 reference
1 January 2015
1 reference
1 reference
Identifiers
1 reference